Lax-Tab

Bisacodyl, the active ingredient in Lax-Tab, is a stimulant laxative presented as an oral tablet for oral use. It is used to relieve constipation and occasional bowel irregularity in adults and adolescents. GNH USA supplies Lax-Tab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Bisacodyl acts on the gastrointestinal tract to promote bowel movements in conditions characterized by reduced motility. - Constipation: provides relief by stimulating colonic peristalsis. - Occasional bowel irregularity: helps normalize stool frequency and consistency. - Travel‑related constipation: facilitates regularity during periods of altered routine.

Bisacodyl may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal cramps - Diarrhea - Nausea - Thirst - Rectal irritation

Serious or Rare Side Effects: - Severe dehydration - Electrolyte imbalance (e.g., hypokalemia) - Allergic reaction (rash, swelling, difficulty breathing) - Acute colitis - Rectal bleeding

Before using Bisacodyl, consider the following safety measures. - Assess renal function: adjust use in patients with impaired kidney function. - Avoid in suspected bowel obstruction or acute abdomen: risk of perforation. - Use with caution in the elderly: increased sensitivity to fluid loss. - Do not exceed recommended duration: prolonged use may cause dependence. - Store at room temperature: keep in the original pack, protect from moisture.

Bisacodyl can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticholinergic drugs: may reduce laxative effectiveness. - Loop diuretics: increase risk of electrolyte disturbances.

Moderate Interactions (Monitor Closely): - Tricyclic antidepressants: may augment anticholinergic load. - Magnesium‑containing antacids: can enhance laxative effect. - Warfarin: monitor INR as altered bowel habits may affect absorption.